Biliary Tract Cancer - 81 Studies Found
| Completed |
: IL-2 Expressing, Attenuated Salmonella Typhimurium in Unresectable Hepatic Spread :
: 2009-06-17 : Radiation: Brachytherapy Brachytherapy, the placement of a radioactive source close to a tumor, is a wel |
| Completed |
: Phase 1 Study Testing the Combination of Aflibercept and Capecitabine in Metastatic Digestive and Breast Cancers :
|
| Completed |
: Diagnostic Laparoscopy in the Preoperative Staging of Pancreatobiliary Cancer : Pancreatic Cancer : 2015-06-08 :
|
| Active, not recruiting |
: A Phase I, Open-Label, Multicentre Study to Evaluate the Safety, Tolerability and Pharmacokinetics of MEDI4736 in Patients With Advanced Solid Tumours : Advanced Solid Tumors : 2013-09-05 :
|
| Completed |
: Isolated Hepatic Perfusion With Melphalan Followed By Chemotherapy in Treating Patients With Unresectable Colorectal Cancer That is Metastatic to the Liver :
|
| Completed |
: Trial of GSK1120212 and GSK1120212 in Combination With GEM in Japanese Subjects With Solid Tumors : Solid Tumours : 2011-01-22 :
|
| Completed |
: Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01) : Biliary Tract Cancer : 2025-08-07 : Rilvegostomig IV (intravenous) Q3W |
| Completed |
: A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002) : Biliary Tract Cancer : 2025-08-07 : IV infusion on day 1 and 14 of every 28 day cycle |
| Completed |
: Durvalumab With Chemotherapy as First Line Treatment in Patients With Advanced Biliary Tract Cancers (aBTCs) : Biliary Tract Cancer : 2025-08-07 : Participants will receive 1500 mg every 3 weeks, or every 4 weeks (in combination with chemotherapy every 3 weeks, or every 2 weeks, respectively) fro |